RELMADA THERAPEUTICS, INC. Increase (Decrease) in Inventories
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Inventories of -$6.12 thousand for the 33-month period ending 2014-02-28, per its 10-Q filed 2014-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2014-04-15
- RELMADA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2014-02-28 was -$1.39K, a 174.53% decline year-over-year.
- RELMADA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2013-11-30 was -$1.56K, a 184.59% decline year-over-year.
- RELMADA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2013-08-31 was -$800.00, a 159.35% decline year-over-year.
- RELMADA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2013-05-31 was $321.00, a 52.65% decline year-over-year.
- RELMADA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2013 was $3.24K, a 559.06% increase from fiscal 2012.
- RELMADA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2012 was $491.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 21 month | Increase (Decrease) in Inventories 24 month | Increase (Decrease) in Inventories 27 month | Increase (Decrease) in Inventories 30 month | Increase (Decrease) in Inventories 33 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-02-28 | -$1.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-15 | -$2.96K 10-Q · filed 2014-04-15 | -$3.75K derived: sum of 3 quarters · filed 2014-04-15 | -$3.43K derived: sum of 4 quarters · filed 2014-04-15 | -$6.12K 10-Q · filed 2014-04-15 | ||||
| 2013-11-30 | -$1.56K 10-Q · filed 2014-01-13 | -$2.37K derived: sum of 2 quarters · filed 2014-01-13 | -$2.04K derived: sum of 3 quarters · filed 2014-01-13 | -$179.00 derived: sum of 4 quarters · filed 2014-04-15 | -$4.73K 10-Q · filed 2014-01-13 | ||||
| 2013-08-31 | -$800.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | -$479.00 derived: sum of 2 quarters · filed 2013-12-16 | $1.39K derived: sum of 3 quarters · filed 2014-04-15 | $3.24K 10-K · filed 2013-12-16 | -$3.17K 10-K · filed 2013-12-16 | ||||
| 2013-05-31 | $321.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-12 | $2.19K derived: sum of 2 quarters · filed 2014-04-15 | $4.04K 10-Q · filed 2013-07-12 | $5.38K derived: sum of 4 quarters · filed 2014-04-15 | -$2.37K 10-Q · filed 2013-07-12 | ||||
| 2013-02-28 | $1.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-15 | $3.71K 10-Q · filed 2014-04-15 | $5.06K derived: sum of 3 quarters · filed 2014-04-15 | $5.74K derived: sum of 4 quarters · filed 2014-04-15 | -$2.69K 10-Q · filed 2013-05-03 | ||||
| 2012-11-30 | $1.85K 10-Q · filed 2014-01-13 | $3.20K derived: sum of 2 quarters · filed 2014-01-13 | $3.88K derived: sum of 3 quarters · filed 2014-01-13 | ||||||
| 2012-08-31 | $1.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | $2.03K derived: sum of 2 quarters · filed 2013-12-16 | $491.00 10-K · filed 2013-12-16 | ||||||
| 2012-05-31 | $678.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-12 | -$857.00 10-Q · filed 2013-07-12 | |||||||
| 2012-02-29 | -$1.53K 10-Q · filed 2013-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |